| Solid-phase synthesis of difficult peptide sequences at elevated temperatures: a critical comparison of microwave and conventional heating technologies B Bacsa, K Horvati, S Bosze, F Andreae, CO Kappe The Journal of organic chemistry 73 (19), 7532-7542, 2008 | 210 | 2008 |
| A road map for prioritizing warheads for cysteine targeting covalent inhibitors P Abranyi-Balogh, L Petri, T Imre, P Szijj, A Scarpino, M Hrast, A Mitrović, ... European journal of medicinal chemistry 160, 94-107, 2018 | 108 | 2018 |
| New fluorine-containing hydrazones active against MDR-tuberculosis E Vavříková, S Polanc, M Kočevar, S Bősze, J Stolaříková, K Vávrová, ... European journal of medicinal chemistry 46 (10), 4937-4945, 2011 | 72 | 2011 |
| Nanoparticle encapsulated lipopeptide conjugate of antitubercular drug isoniazid: in vitro intracellular activity and in vivo efficacy in a Guinea pig model of tuberculosis K Horvati, B Bacsa, É Kiss, G Gyulai, K Fodor, G Balka, M Rusvai, ... Bioconjugate chemistry 25 (12), 2260-2268, 2014 | 51 | 2014 |
| New series of isoniazid hydrazones linked with electron-withdrawing substituents E Vavříková, S Polanc, M Kočevar, J Košmrlj, S Bősze, J Stolaříková, ... European journal of medicinal chemistry 46 (12), 5902-5909, 2011 | 51 | 2011 |
| New amino acid esters of salicylanilides active against MDR-TB and other microbes M Krátký, J Vinšová, V Buchta, S Bösze, J Stolaříková European journal of medicinal chemistry 45 (12), 6106-6113, 2010 | 47 | 2010 |
| Enhanced Cellular Uptake of a New, in Silico Identified Antitubercular Candidate by Peptide Conjugation K Horváti, B Bacsa, N Szabó, S Dávid, G Mező, V Grolmusz, B Vértessy, ... Bioconjugate chemistry 23 (5), 900-907, 2012 | 41 | 2012 |
| Antimycobacterial activity of peptide conjugate of pyridopyrimidine derivative against Mycobacterium tuberculosis in a series of in vitro and in vivo models B Bacsa, N Szabó, K Fodor, G Balka, M Rusvai, É Kiss, G Mező, ... Tuberculosis 95, S207-S211, 2015 | 37 | 2015 |
| Chemical structure and in vitro cellular uptake of luminescent carbon quantum dots prepared by solvothermal and microwave assisted techniques G Gyulai, F Ouanzi, I Bertóti, M Mohai, T Kolonits, S Bősze Journal of colloid and interface science 549, 150-161, 2019 | 35 | 2019 |
| Comparative analysis of internalisation, haemolytic, cytotoxic and antibacterial effect of membrane-active cationic peptides: Aspects of experimental setup K Horváti, B Bacsa, T Mlinkó, N Szabó, F Hudecz, F Zsila, S Bősze Amino Acids 49, 1053-1067, 2017 | 33 | 2017 |
| Peptide conjugates of therapeutically used antitubercular isoniazid—design, synthesis and antimycobacterial effect K Horvati, G Mező, N Szabo, F Hudecz, S Bősze Journal of Peptide Science: An Official Publication of the European Peptide …, 2009 | 33 | 2009 |
| Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates Z Baranyai, M Krátký, J Vinšová, N Szabó, Z Senoner, J Stolaříková, ... European journal of medicinal chemistry 101, 692-704, 2015 | 32 | 2015 |
| Tuneable surface modification of PLGA nanoparticles carrying new antitubercular drug candidate É Kiss, G Gyulai, CB Pénzes, M Idei, K Horváti, B Bacsa, S Bősze Colloids and Surfaces A: Physicochemical and Engineering Aspects 458, 178-186, 2014 | 32 | 2014 |
| Surface Layer Modification of Poly(d,l-lactic-co-glycolic acid) Nanoparticles with Targeting Peptide: A Convenient Synthetic Route for Pluronic F127–Tuftsin … K Horváti, G Gyulai, A Csámpai, J Rohonczy, E Kiss, S Bősze Bioconjugate chemistry 29 (5), 1495-1499, 2018 | 29 | 2018 |
| Recent advances in the development of protein-and peptide-based subunit vaccines against tuberculosis C Bellini, K Horvati Cells 9 (12), 2673, 2020 | 27 | 2020 |
| Nanoencapsulation of antitubercular drug isoniazid and its lipopeptide conjugate É Kiss, D Schnöller, K Pribranska, K Hill, CB Pénzes, K Horváti, S Bősze Journal of dispersion science and technology 32 (12), 1728-1734, 2011 | 27 | 2011 |
| Manipulating active structure and function of cationic antimicrobial peptide CM15 with the polysulfonated drug suramin: a step closer to in vivo complexity M Quemé‐Peña, T Juhász, J Mihály, I Cs. Szigyártó, K Horváti, S Bősze, ... ChemBioChem 20 (12), 1578-1590, 2019 | 21 | 2019 |
| Hemin and bile pigments are the secondary structure regulators of intrinsically disordered antimicrobial peptides F Zsila, T Juhász, S Bősze, K Horvati, T Beke‐Somfai Chirality 30 (2), 195-205, 2018 | 21 | 2018 |
| Cytotoxicity decreasing effect and antimycobacterial activity of chitosan conjugated with antituberculotic drugs E Vavříková, J Mandíková, F Trejtnar, S Bösze, J Stolaříková, J Vinšová Carbohydrate polymers 83 (4), 1901-1907, 2011 | 21 | 2011 |
| Drug and dye binding induced folding of the intrinsically disordered antimicrobial peptide CM15 F Zsila, S Bősze, IC Szigyártó, T Beke-Somfai RSC advances 7 (65), 41091-41097, 2017 | 20 | 2017 |
Mario RoedererVaccine Research Center, NIAID, NIHVerified email at nih.gov
